Redhill Biopharma
RDHL
$0.43
Share price
2.22%
Change (1 day)
-81.23%
Change (1 year)
Categories
Redhill Biopharma (RDHL) - Cash on Hand
Cash on Hand as of June 2023 : $7.01 M
According to Redhill Biopharma's latest financial reports the company has $7.01 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Redhill Biopharma - Cash on Hand chart (from 2011 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $19.98 M | -47.42% |
| 2021-12-31 | $38 M | 27.56% |
| 2020-12-31 | $29.79 M | -37.77% |
| 2019-12-31 | $47.87 M | -9.99% |
| 2018-12-31 | $53.18 M | 15.11% |
| 2017-12-31 | $46.2 M | -30.16% |
| 2016-12-31 | $66.15 M | 13.79% |
| 2015-12-31 | $58.13 M | 153.38% |
| 2014-12-31 | $22.94 M | 89.42% |
| 2013-12-31 | $12.11 M | -34.04% |
| 2012-12-31 | $18.36 M | -1.51% |
| 2011-12-31 | $18.64 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $9.92 B | 141,447.48% | 🇫🇷 France |
 Merck MRK | $7.09 B | 101,026.32% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | 90,501.94% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 45,893.73% | 🇮🇱 Israel |
 Taro Pharmaceutical TARO | $0.90 B | 12,763.07% | 🇮🇱 Israel |